Cargando…
Disease Burden in Patients with von Willebrand Disease Potentially Eligible for Prophylaxis: Post Hoc Analysis of a European Cross-Sectional Study
Recent international guidelines conditionally recommend von Willebrand factor (VWF) prophylaxis for von Willebrand disease (VWD) patients with a history of severe/frequent bleeds. This post hoc analysis of the Cost of VWD Across Europe, a Socioeconomic Study (CVESS; conducted in 2018), assessed pati...
Autores principales: | Du, Ping, Morgan, George, Brighton, Sarah, Sun, Shawn X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720832/ https://www.ncbi.nlm.nih.gov/pubmed/36453002 http://dx.doi.org/10.1177/10760296221130334 |
Ejemplares similares
-
Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart Review
por: Sun, Shawn X., et al.
Publicado: (2023) -
The Cost of Von Willebrand Disease in Europe: The CVESS
Study
por: Morgan, George, et al.
Publicado: (2022) -
Burden of Illness and Treatment Patterns Among Patients With von Willebrand Disease in US Clinical Practice
por: Swallow, Elyse, et al.
Publicado: (2023) -
Von Willebrand Disease in Older Patients: A Retrospective Electronic Health Record Review
por: Seaman, Craig D.
Publicado: (2022) -
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022)